Cargando…

Down‐regulation of PKM2 enhances anticancer efficiency of THP on bladder cancer

Pyruvate kinase M2 (PKM2) regulates the final step of glycolysis levels that are correlated with the sensitivity of anticancer chemotherapeutic drugs. THP is one of the major drugs used in non‐muscle‐invasive bladder cancer instillation chemotherapy. However, low response ratio of THP (19.7%) treatm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Qiongli, Tao, Ting, Tang, Lei, Deng, Jun, Darko, Kwame Oteng, Zhou, Sichun, Peng, Mei, He, Shanping, Zeng, Qing, Chen, Alex F., Yang, Xiaoping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908113/ https://www.ncbi.nlm.nih.gov/pubmed/29512924 http://dx.doi.org/10.1111/jcmm.13571

Ejemplares similares

Phenformin alone or combined with gefitinib inhibits bladder cancer via AMPK and EGFR pathways
por: Huang, Yanjun, et al.
Publicado: (2018)

The molecular mechanisms of LncRNA-correlated PKM2 in cancer metabolism
por: Tao, Ting, et al.
Publicado: (2019)

Metformin and gefitinib cooperate to inhibit bladder cancer growth via both AMPK and EGFR pathways joining at Akt and Erk
por: Peng, Mei, et al.
Publicado: (2016)

A novel synthetic derivative of quercetin, 8-trifluoromethyl-3,5,7,3′,4′-O-pentamethyl-quercetin, inhibits bladder cancer growth by targeting the AMPK/mTOR signaling pathway
por: Tao, Ting, et al.
Publicado: (2017)

The role of pyruvate kinase M2 in anticancer therapeutic treatments
por: Su, Qiongli, et al.
Publicado: (2019)

The role of Clusterin in cancer metastasis
por: Peng, Mei, et al.
Publicado: (2019)

Inhibition of PKM2 Enhances Sensitivity of Olaparib to Ovarian Cancer Cells and Induces DNA Damage
por: Zhou, Sichun, et al.
Publicado: (2022)

Novel application of metformin combined with targeted drugs on anticancer treatment
por: Deng, Jun, et al.
Publicado: (2018)

High efficacy of intravesical treatment of metformin on bladder cancer in preclinical model
por: Peng, Mei, et al.
Publicado: (2016)

AB046. The evaluation of therapeutic efficiency of relapse prevention of alternating bladder perfusion with GEM and THP after TURBT of superficial bladder cancer
por: Zheng, Shuhong
Publicado: (2016)

Shock Wave and THP‐Adriamycin for Treatment of Rabbit's Bladder Cancer
por: Hoshi, Senji, et al.
Publicado: (1992)

PKM2 and cancer: The function of PKM2 beyond glycolysis
por: DONG, GAOCHAO, et al.
Publicado: (2016)

Metformin targets Clusterin to control lipogenesis and inhibit the growth of bladder cancer cells through SREBP-1c/FASN axis
por: Deng, Jun, et al.
Publicado: (2021)

Inhibitory role of proguanil on the growth of bladder cancer via enhancing EGFR degradation and inhibiting its downstream signaling pathway to induce autophagy
por: Xiao, Di, et al.
Publicado: (2022)

Dual Inhibition of Pirarubicin-Induced AKT and ERK Activations by Phenformin Sensitively Suppresses Bladder Cancer Growth
por: Peng, Mei, et al.
Publicado: (2019)

PKM2, function and expression and regulation
por: Zhang, Ze, et al.
Publicado: (2019)

PKM2 Inhibitor Shikonin Overcomes the Cisplatin Resistance in Bladder Cancer by Inducing Necroptosis
por: Wang, Yonggang, et al.
Publicado: (2018)

PKM and the maintenance of memory
por: Glanzman, David L.
Publicado: (2013)

Effects of Buzhong Yiqi Decoction Combined with THP Bladder Perfusion on Postoperative Efficacy in Patients with Bladder Cancer
por: Wang, Yunfeng, et al.
Publicado: (2021)

A feedback loop between NONHSAT024276 and PTBP1 inhibits tumor progression and glycolysis in HCC by increasing the PKM1/PKM2 ratio
por: Li, Yuwei, et al.
Publicado: (2022)

Highly Efficient Transfection of Human THP-1 Macrophages by Nucleofection
por: Maeß, Marten B., et al.
Publicado: (2014)

Correction to: PKM2, function and expression and regulation
por: Zhang, Ze, et al.
Publicado: (2019)

The role of the HIF‐1α/ALYREF/PKM2 axis in glycolysis and tumorigenesis of bladder cancer
por: Wang, Jing‐Zi, et al.
Publicado: (2021)

PKM2 in carcinogenesis and oncotherapy
por: He, Xia, et al.
Publicado: (2017)

No evidence for a shift in pyruvate kinase PKM1 to PKM2 expression during tumorigenesis
por: Bluemlein, Katharina, et al.
Publicado: (2011)

Prioritizing potential circRNA biomarkers for bladder cancer and bladder urothelial cancer based on an ensemble model
por: Su, Qiongli, et al.
Publicado: (2022)

RBMX suppresses tumorigenicity and progression of bladder cancer by interacting with the hnRNP A1 protein to regulate PKM alternative splicing
por: Yan, Qiuxia, et al.
Publicado: (2021)

Synergistic Combination of Gemcitabine and Dietary Molecule Induces Apoptosis in Pancreatic Cancer Cells and Down Regulates PKM2 Expression
por: Pandita, Archana, et al.
Publicado: (2014)

UCHL1-PKM2 axis dysregulation is associated with promoted proliferation and invasiveness of urothelial bladder cancer cells
por: Zheng, Yuhui, et al.
Publicado: (2023)

Structural basis of PKM2 regulation
por: Yang, Weiwei
Publicado: (2015)

The Role of PKM2 in Diabetic Microangiopathy
por: Tu, Chao, et al.
Publicado: (2022)

Overexpressed PKM2 promotes macrophage phagocytosis and atherosclerosis
por: Gai, Xiaochen, et al.
Publicado: (2022)

MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in gastric cancer
por: Tang, Ran, et al.
Publicado: (2016)

MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in cervical cancer
por: Guo, Man, et al.
Publicado: (2017)

Mechanism of PKM2 affecting cancer immunity and metabolism in Tumor Microenvironment
por: Chen, Mengxi, et al.
Publicado: (2021)

PKM2 Is a Potential Diagnostic and Therapeutic Target for Retinitis Pigmentosa
por: Zhu, Peiwen, et al.
Publicado: (2021)

Docking and ADMET studies for investigating the anticancer potency of Moscatilin on APC10/DOC1 and PKM2 against five clinical drugs
por: Pujari, Ipsita, et al.
Publicado: (2021)

PKM2 functions as a histone kinase
por: Lu, Zhimin
Publicado: (2012)

Memory maintenance by PKMζ — an evolutionary perspective
por: Sacktor, Todd Charlton
Publicado: (2012)

PKM2 promotes reductive glutamine metabolism
por: Liu, Miao, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bged11tljh61n387hn0rg0mm7k